Methods for treating juvenile arthritis with ant-bile salt-stimulated lipase (BSSL) antibodies
AssigneeLipum AB
InventorsOlle Hernell, Susanne Lindquist, Lennart Gustav Lundberg
Life of this patent
Estimating the term…
Abstract
It provides methods and pharmaceutical compositions comprising antagonists to the protein Bile Salt-Stimulated Lipase (BSSL) for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. It further relates to pharmaceutical compositions comprising BSSL antagonists and their use in methods for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. Suitable BSSL antagonists to be used according to the invention are BSSL antibodies.
Claims2
A method for treating juvenile arthritis comprising administering a pharmaceutical effective amount of a BSSL antagonist comprising an antibody or an antibody fragment specifically binding to human bile salt-stimulated lipase (BSSL) to a subject in need of such treatment.
Dependencies are inferred from the claim text.